Clinical Trials Browser

Phase 1 × Interventional × Fondaparinux × Clear all

NCT00659399 2015-03-18

Feasibility Study of Short Term Fondaparinux (Arixtra) in Chemotherapy-Pretreated Ovarian Carcinoma Patients at High Risk of Progression

Phase 1 Withdrawn

Ovarian Neoplasms

NCT00476216 2014-03-05

Fondaparinux (Arixtra) With Chemotherapy for Advanced Non-Small Cell Lung Cancer

Phase 1 Completed

Classical hematologyThoracic

Carcinoma, Non-Small-Cell Lung, Venous Thromboembolism